Skip to main content
. 2021 Jun 7;11(6):849. doi: 10.3390/biom11060849

Table 1.

Knockout mouse models of the Notch signaling pathway.

Knockout Genotype Embryonic Lethality Developmental Impairment References
Notch1 −/− Yes (E9.5) Somitogenesis
Neurogenesis
Developmental impairment
[24,25]
Notch2 −/− Yes (E11.5) Wide-spread pycnosis and apoptosis [26]
Notch3 −/− No Vascular and arterial development [27]
Notch1 & Notch3 Notch1: −/−
Notch3: −/−
Yes (E9.5) Somitogenesis
Neurogenesis
Developmental impairment
[28]
Notch4 −/− No Vasculature of embryonic head [29,30]
Notch1 & Notch4 Notch1: −/−
Notch4: −/−
Yes (E10.5) Vascular development
Developmental impairment (more severe than Notch1 knockout)
[29]
Dll1 −/− Yes (E10–E12) Somitogenesis [31]
Dll3 −/− Yes (~20%) Somitogenesis
Skeletal deformities
[32]
Dll4 −/− Yes (E8.5) Vascular and arterial development [33]
Dll4 +/− Yes (E9.5–E10.5) Vascular and arterial development [33,34,35]
Jagged1 −/− Yes (E10.5) Vascular development [36]
Jagged2 −/− Yes (E10.5) Craniofacial and skeletal deformities [37,38]
Cbf1 −/− Yes (E8.5) Somitogenesis
Placenta defects
[23]
Adam10 −/− Yes (E9.5) Somitogenesis
Heart and neural defects
[17]
Adam17/Tace −/− Yes (E17.5) Eyes and lungs defects [16]

−/−: Homozygous Knockout; +/−: Heterozygous Knockout; Adam10: A disintegrin and metalloproteases 10; Cbf1: C-promoter binding factor 1; Dll: Delta-like; E: postimplantation days; Jag: Jagged; Tace: ADAM17/Tumor-necrosis-factor (TNF) α converting enzyme.